 Monika Fleshner
Concepts (681)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 57 | 2017 | 944 | 7.950 |
Why?
| | Stress, Physiological | 45 | 2019 | 378 | 7.370 |
Why?
| | Physical Conditioning, Animal | 21 | 2019 | 194 | 4.410 |
Why?
| | Rats, Inbred F344 | 45 | 2019 | 241 | 3.430 |
Why?
| | Rats | 130 | 2021 | 4958 | 3.420 |
Why?
| | Prebiotics | 6 | 2021 | 23 | 3.250 |
Why?
| | HSP72 Heat-Shock Proteins | 15 | 2014 | 26 | 3.190 |
Why?
| | Helplessness, Learned | 13 | 2016 | 61 | 3.090 |
Why?
| | Motor Activity | 25 | 2019 | 640 | 3.030 |
Why?
| | Corticosterone | 37 | 2016 | 211 | 2.320 |
Why?
| | Running | 14 | 2016 | 207 | 2.310 |
Why?
| | Brain | 25 | 2019 | 2371 | 2.120 |
Why?
| | Animals | 155 | 2021 | 31706 | 1.830 |
Why?
| | Fear | 17 | 2015 | 293 | 1.590 |
Why?
| | Circadian Rhythm | 7 | 2021 | 354 | 1.550 |
Why?
| | Cytokines | 15 | 2016 | 1841 | 1.530 |
Why?
| | Exosomes | 5 | 2017 | 92 | 1.440 |
Why?
| | Electroshock | 26 | 2015 | 134 | 1.430 |
Why?
| | Escherichia coli Infections | 7 | 2012 | 100 | 1.360 |
Why?
| | Rats, Sprague-Dawley | 67 | 2021 | 2218 | 1.350 |
Why?
| | Immune System | 8 | 2017 | 172 | 1.330 |
Why?
| | Interleukin-1beta | 6 | 2016 | 370 | 1.320 |
Why?
| | Heat-Shock Proteins | 7 | 2006 | 113 | 1.260 |
Why?
| | Immunity, Innate | 9 | 2014 | 720 | 1.240 |
Why?
| | Hemocyanins | 17 | 2008 | 55 | 1.230 |
Why?
| | Anxiety | 10 | 2018 | 840 | 1.230 |
Why?
| | Inflammasomes | 3 | 2016 | 115 | 1.230 |
Why?
| | Corpus Striatum | 7 | 2017 | 126 | 1.220 |
Why?
| | Proto-Oncogene Proteins c-fos | 11 | 2019 | 164 | 1.210 |
Why?
| | Exercise | 15 | 2016 | 1644 | 1.210 |
Why?
| | Inflammation | 10 | 2016 | 2479 | 1.200 |
Why?
| | Gastrointestinal Tract | 3 | 2016 | 169 | 1.200 |
Why?
| | Physical Exertion | 6 | 2012 | 209 | 1.180 |
Why?
| | Lactoferrin | 2 | 2018 | 28 | 1.140 |
Why?
| | Bacteria | 6 | 2020 | 725 | 1.140 |
Why?
| | Spleen | 12 | 2013 | 487 | 1.120 |
Why?
| | Male | 137 | 2021 | 55589 | 1.120 |
Why?
| | Neuronal Plasticity | 12 | 2018 | 209 | 1.090 |
Why?
| | Serotonin | 10 | 2019 | 292 | 1.080 |
Why?
| | MicroRNAs | 3 | 2017 | 600 | 0.970 |
Why?
| | Amygdala | 7 | 2017 | 170 | 0.970 |
Why?
| | Diet | 4 | 2021 | 1080 | 0.950 |
Why?
| | Sympathetic Nervous System | 4 | 2014 | 171 | 0.950 |
Why?
| | Receptors, Adrenergic, alpha-1 | 7 | 2014 | 41 | 0.900 |
Why?
| | Hippocampus | 18 | 2017 | 693 | 0.900 |
Why?
| | Immunoglobulin M | 10 | 2008 | 246 | 0.900 |
Why?
| | Behavior, Animal | 13 | 2019 | 458 | 0.860 |
Why?
| | Raphe Nuclei | 7 | 2019 | 110 | 0.850 |
Why?
| | Interleukin-1 | 14 | 2008 | 966 | 0.830 |
Why?
| | Adipose Tissue | 3 | 2016 | 540 | 0.820 |
Why?
| | Antibody Formation | 9 | 2008 | 266 | 0.800 |
Why?
| | Conditioning, Classical | 7 | 2015 | 87 | 0.800 |
Why?
| | Glycolipids | 2 | 2019 | 35 | 0.750 |
Why?
| | Stress Disorders, Post-Traumatic | 8 | 2021 | 758 | 0.730 |
Why?
| | Feces | 2 | 2020 | 373 | 0.720 |
Why?
| | Neuroendocrine Cells | 1 | 2020 | 30 | 0.720 |
Why?
| | Catecholamines | 7 | 2014 | 94 | 0.710 |
Why?
| | Microbiota | 2 | 2019 | 647 | 0.710 |
Why?
| | Dopamine | 3 | 2015 | 236 | 0.700 |
Why?
| | Bile Acids and Salts | 1 | 2021 | 171 | 0.700 |
Why?
| | Conditioning, Operant | 5 | 2012 | 97 | 0.690 |
Why?
| | Lipopolysaccharides | 9 | 2014 | 823 | 0.680 |
Why?
| | Gene Expression Regulation | 8 | 2014 | 2320 | 0.680 |
Why?
| | Receptor, Serotonin, 5-HT2C | 4 | 2012 | 14 | 0.670 |
Why?
| | Glycoproteins | 2 | 2019 | 304 | 0.670 |
Why?
| | Sleep | 4 | 2021 | 631 | 0.670 |
Why?
| | Tumor Necrosis Factor-alpha | 7 | 2016 | 1140 | 0.650 |
Why?
| | Immunoglobulin G | 11 | 2008 | 770 | 0.650 |
Why?
| | Mentors | 1 | 2021 | 156 | 0.640 |
Why?
| | Microglia | 2 | 2021 | 202 | 0.640 |
Why?
| | Gastrointestinal Microbiome | 3 | 2020 | 501 | 0.630 |
Why?
| | Prefrontal Cortex | 5 | 2017 | 262 | 0.630 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2018 | 106 | 0.630 |
Why?
| | Interleukin-10 | 7 | 2016 | 299 | 0.610 |
Why?
| | Signal Transduction | 10 | 2023 | 4513 | 0.590 |
Why?
| | Fatigue | 3 | 2012 | 294 | 0.590 |
Why?
| | Alarmins | 1 | 2017 | 25 | 0.580 |
Why?
| | Food Deprivation | 1 | 2016 | 24 | 0.550 |
Why?
| | Inflammation Mediators | 4 | 2013 | 477 | 0.550 |
Why?
| | Vagus Nerve | 7 | 2000 | 79 | 0.550 |
Why?
| | Escape Reaction | 6 | 2012 | 58 | 0.550 |
Why?
| | Emotions | 3 | 2018 | 472 | 0.540 |
Why?
| | RNA, Messenger | 12 | 2018 | 2553 | 0.530 |
Why?
| | Analysis of Variance | 15 | 2015 | 1226 | 0.530 |
Why?
| | Body Weight | 12 | 2016 | 869 | 0.520 |
Why?
| | Central Nervous System | 2 | 2016 | 235 | 0.520 |
Why?
| | Butyrates | 1 | 2016 | 53 | 0.520 |
Why?
| | Sleep, REM | 1 | 2016 | 50 | 0.520 |
Why?
| | Receptors, Glucocorticoid | 4 | 2013 | 130 | 0.520 |
Why?
| | Association Learning | 3 | 2010 | 60 | 0.500 |
Why?
| | Neuroimmunomodulation | 8 | 2003 | 70 | 0.500 |
Why?
| | Mood Disorders | 1 | 2016 | 112 | 0.500 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1737 | 0.500 |
Why?
| | Interleukin-6 | 7 | 2016 | 676 | 0.490 |
Why?
| | Macrophages, Peritoneal | 2 | 2014 | 93 | 0.490 |
Why?
| | Norepinephrine | 6 | 2006 | 201 | 0.480 |
Why?
| | Interleukin-18 | 2 | 2012 | 219 | 0.470 |
Why?
| | Chemokines | 2 | 2012 | 216 | 0.470 |
Why?
| | Serum | 1 | 2014 | 57 | 0.460 |
Why?
| | Adaptation, Physiological | 6 | 2007 | 483 | 0.460 |
Why?
| | Sleep Deprivation | 4 | 2020 | 166 | 0.450 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2016 | 204 | 0.450 |
Why?
| | Arousal | 9 | 2021 | 152 | 0.440 |
Why?
| | Receptors, Adrenergic | 1 | 2013 | 35 | 0.440 |
Why?
| | Adipose Tissue, White | 1 | 2013 | 27 | 0.440 |
Why?
| | Reward | 3 | 2016 | 211 | 0.440 |
Why?
| | Receptor, Serotonin, 5-HT1A | 3 | 2016 | 39 | 0.430 |
Why?
| | Chemokine CCL2 | 4 | 2014 | 105 | 0.430 |
Why?
| | Time Factors | 23 | 2016 | 6115 | 0.420 |
Why?
| | Glucocorticoids | 5 | 2012 | 532 | 0.420 |
Why?
| | Respiratory Tract Infections | 2 | 2016 | 319 | 0.420 |
Why?
| | Psychoneuroimmunology | 3 | 2005 | 11 | 0.420 |
Why?
| | Immune Tolerance | 3 | 2005 | 323 | 0.420 |
Why?
| | Transcortin | 6 | 2007 | 14 | 0.410 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2021 | 485 | 0.410 |
Why?
| | Intestines | 1 | 2015 | 326 | 0.410 |
Why?
| | Injections, Intraperitoneal | 11 | 2008 | 99 | 0.400 |
Why?
| | Antigens | 4 | 2003 | 318 | 0.400 |
Why?
| | Obesity, Abdominal | 1 | 2012 | 37 | 0.400 |
Why?
| | Aminopyridines | 3 | 2009 | 81 | 0.390 |
Why?
| | Mental Health | 2 | 2015 | 562 | 0.390 |
Why?
| | Neurons | 8 | 2017 | 1280 | 0.380 |
Why?
| | Myeloid Cells | 1 | 2012 | 126 | 0.380 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 333 | 0.370 |
Why?
| | Depression | 3 | 2012 | 1134 | 0.370 |
Why?
| | Body Temperature | 5 | 2014 | 208 | 0.370 |
Why?
| | Memory | 9 | 2015 | 211 | 0.360 |
Why?
| | Disease Models, Animal | 13 | 2016 | 3535 | 0.360 |
Why?
| | Mifepristone | 3 | 2001 | 60 | 0.360 |
Why?
| | Limbic System | 1 | 2010 | 43 | 0.360 |
Why?
| | Freezing Reaction, Cataleptic | 4 | 2012 | 22 | 0.350 |
Why?
| | Indoles | 3 | 2009 | 304 | 0.350 |
Why?
| | Metagenome | 1 | 2010 | 122 | 0.340 |
Why?
| | Exercise Therapy | 3 | 2008 | 352 | 0.340 |
Why?
| | Volition | 1 | 2009 | 31 | 0.340 |
Why?
| | Random Allocation | 3 | 2016 | 335 | 0.330 |
Why?
| | Extracellular Fluid | 3 | 2006 | 30 | 0.330 |
Why?
| | Brain Chemistry | 3 | 2005 | 115 | 0.330 |
Why?
| | Locomotion | 2 | 2012 | 80 | 0.330 |
Why?
| | Space Flight | 2 | 2000 | 127 | 0.320 |
Why?
| | Electric Stimulation | 9 | 2013 | 250 | 0.320 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 10 | 0.320 |
Why?
| | Lipid Droplets | 2 | 2019 | 21 | 0.320 |
Why?
| | Predatory Behavior | 5 | 2011 | 39 | 0.320 |
Why?
| | Exercise Test | 3 | 2007 | 544 | 0.310 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 7 | 2014 | 797 | 0.310 |
Why?
| | Fluvoxamine | 1 | 2008 | 12 | 0.310 |
Why?
| | B-Lymphocytes | 2 | 2003 | 766 | 0.300 |
Why?
| | Homeostasis | 3 | 2017 | 573 | 0.300 |
Why?
| | Humans | 44 | 2023 | 114674 | 0.300 |
Why?
| | Antibodies | 3 | 2005 | 371 | 0.300 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2008 | 127 | 0.290 |
Why?
| | Pituitary-Adrenal System | 4 | 2012 | 130 | 0.290 |
Why?
| | Mycobacterium | 2 | 2021 | 103 | 0.290 |
Why?
| | Adrenalectomy | 11 | 2005 | 60 | 0.290 |
Why?
| | Extinction, Psychological | 3 | 2015 | 78 | 0.280 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2012 | 164 | 0.280 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.270 |
Why?
| | Heart Rate | 6 | 2016 | 709 | 0.270 |
Why?
| | Physical Fitness | 2 | 2006 | 179 | 0.270 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 86 | 0.270 |
Why?
| | Extracellular Space | 2 | 2005 | 116 | 0.260 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 430 | 0.260 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2005 | 28 | 0.260 |
Why?
| | Neural Pathways | 4 | 2015 | 261 | 0.250 |
Why?
| | Vagotomy | 8 | 2000 | 34 | 0.250 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 5 | 0.250 |
Why?
| | Heat-Shock Response | 1 | 2005 | 46 | 0.250 |
Why?
| | Physical Endurance | 1 | 2006 | 232 | 0.250 |
Why?
| | Immunomodulation | 2 | 2017 | 84 | 0.240 |
Why?
| | In Situ Hybridization | 4 | 2012 | 292 | 0.240 |
Why?
| | Adrenocorticotropic Hormone | 7 | 2013 | 128 | 0.240 |
Why?
| | Adrenal Glands | 7 | 2008 | 66 | 0.240 |
Why?
| | Psychomotor Performance | 3 | 2019 | 280 | 0.240 |
Why?
| | Long-Term Potentiation | 7 | 1999 | 145 | 0.230 |
Why?
| | Sick Role | 1 | 2004 | 18 | 0.230 |
Why?
| | Memory Disorders | 3 | 2013 | 155 | 0.230 |
Why?
| | Cognition | 5 | 2019 | 989 | 0.230 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 138 | 0.220 |
Why?
| | Morphine | 5 | 2011 | 121 | 0.220 |
Why?
| | Lung | 1 | 2016 | 3561 | 0.220 |
Why?
| | Encephalitis | 1 | 2005 | 127 | 0.220 |
Why?
| | Adjuvants, Immunologic | 3 | 2003 | 206 | 0.220 |
Why?
| | Social Behavior | 4 | 2016 | 267 | 0.220 |
Why?
| | CD5 Antigens | 1 | 2003 | 8 | 0.220 |
Why?
| | Protein Biosynthesis | 1 | 2005 | 386 | 0.210 |
Why?
| | Muscle Strength | 1 | 2006 | 270 | 0.210 |
Why?
| | CD11 Antigens | 1 | 2003 | 30 | 0.210 |
Why?
| | Hypothalamus | 4 | 2017 | 147 | 0.210 |
Why?
| | Propranolol | 3 | 2008 | 49 | 0.210 |
Why?
| | Genes, fos | 1 | 2003 | 33 | 0.210 |
Why?
| | Nitric Oxide | 4 | 2014 | 823 | 0.200 |
Why?
| | Microdialysis | 4 | 2015 | 49 | 0.200 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2000 | 959 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 9 | 2013 | 1842 | 0.200 |
Why?
| | Sex Characteristics | 2 | 2006 | 640 | 0.200 |
Why?
| | Depressive Disorder | 3 | 2012 | 332 | 0.200 |
Why?
| | Maze Learning | 6 | 2015 | 86 | 0.190 |
Why?
| | T-Lymphocyte Subsets | 2 | 1995 | 383 | 0.190 |
Why?
| | Dehydroepiandrosterone | 3 | 1997 | 49 | 0.190 |
Why?
| | Bacteroidetes | 1 | 2021 | 20 | 0.190 |
Why?
| | Interferon-gamma | 4 | 2001 | 719 | 0.190 |
Why?
| | Dehydroepiandrosterone Sulfate | 3 | 1999 | 45 | 0.190 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 529 | 0.190 |
Why?
| | Tyrosine 3-Monooxygenase | 3 | 2016 | 68 | 0.190 |
Why?
| | Gene Expression | 2 | 2018 | 1421 | 0.180 |
Why?
| | Weightlessness Simulation | 1 | 2000 | 13 | 0.180 |
Why?
| | Immunization | 5 | 2021 | 397 | 0.180 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 287 | 0.180 |
Why?
| | Pituitary Gland | 5 | 2006 | 148 | 0.180 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2013 | 29 | 0.180 |
Why?
| | Acoustic Stimulation | 7 | 2015 | 314 | 0.180 |
Why?
| | Weightlessness | 1 | 2000 | 79 | 0.170 |
Why?
| | Neurosecretory Systems | 1 | 2000 | 32 | 0.170 |
Why?
| | Mental Recall | 4 | 1997 | 171 | 0.170 |
Why?
| | Radiation Effects | 1 | 1999 | 4 | 0.170 |
Why?
| | Myocardium | 3 | 2007 | 913 | 0.170 |
Why?
| | Astronauts | 1 | 1999 | 18 | 0.170 |
Why?
| | Exploratory Behavior | 3 | 2015 | 82 | 0.170 |
Why?
| | Avoidance Learning | 2 | 2013 | 63 | 0.170 |
Why?
| | Dentate Gyrus | 2 | 2010 | 30 | 0.170 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 347 | 0.170 |
Why?
| | Fever | 3 | 2011 | 280 | 0.170 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 24 | 0.160 |
Why?
| | Citrate (si)-Synthase | 4 | 2007 | 46 | 0.160 |
Why?
| | Tryptophan Hydroxylase | 1 | 2019 | 52 | 0.160 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 37 | 0.160 |
Why?
| | Prazosin | 2 | 2011 | 24 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 411 | 0.160 |
Why?
| | RNA, Bacterial | 1 | 2020 | 174 | 0.160 |
Why?
| | Lymph Nodes | 4 | 2006 | 419 | 0.160 |
Why?
| | Serotonin 5-HT2 Receptor Agonists | 2 | 2008 | 6 | 0.160 |
Why?
| | Analgesics, Opioid | 3 | 2012 | 771 | 0.150 |
Why?
| | Up-Regulation | 3 | 2012 | 808 | 0.150 |
Why?
| | Dexamethasone | 3 | 2001 | 317 | 0.150 |
Why?
| | Toll-Like Receptors | 2 | 2011 | 167 | 0.150 |
Why?
| | Cats | 5 | 2015 | 193 | 0.150 |
Why?
| | Peptides | 2 | 2013 | 848 | 0.150 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 646 | 0.140 |
Why?
| | Exercise Movement Techniques | 1 | 2016 | 4 | 0.140 |
Why?
| | Aging | 3 | 2004 | 1618 | 0.140 |
Why?
| | Immunoglobulins | 1 | 1996 | 143 | 0.130 |
Why?
| | Leukocyte Count | 3 | 2002 | 293 | 0.130 |
Why?
| | Behavior | 2 | 2006 | 92 | 0.130 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2016 | 151 | 0.130 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1472 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 68 | 0.130 |
Why?
| | Bacterial Vaccines | 1 | 2016 | 61 | 0.130 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2016 | 106 | 0.130 |
Why?
| | Dysgammaglobulinemia | 1 | 1995 | 2 | 0.130 |
Why?
| | IgG Deficiency | 1 | 1995 | 8 | 0.130 |
Why?
| | Leptin | 1 | 2016 | 210 | 0.120 |
Why?
| | Host-Pathogen Interactions | 2 | 2015 | 295 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 126 | 0.120 |
Why?
| | Metabolomics | 1 | 2020 | 521 | 0.120 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 75 | 0.120 |
Why?
| | Symbiosis | 1 | 2015 | 64 | 0.120 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1995 | 41 | 0.120 |
Why?
| | CD4 Antigens | 1 | 1995 | 123 | 0.120 |
Why?
| | Hydrocortisone | 3 | 2015 | 267 | 0.120 |
Why?
| | Blood Proteins | 1 | 1997 | 231 | 0.120 |
Why?
| | Neuralgia | 1 | 2016 | 122 | 0.120 |
Why?
| | Enkephalins | 1 | 2014 | 13 | 0.120 |
Why?
| | Tyrosine | 2 | 2005 | 214 | 0.120 |
Why?
| | Dynorphins | 1 | 2014 | 9 | 0.120 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 11 | 0.120 |
Why?
| | Anxiety Disorders | 2 | 2008 | 303 | 0.120 |
Why?
| | Culture Media | 1 | 2014 | 155 | 0.120 |
Why?
| | Receptors, Dopamine D1 | 1 | 2014 | 25 | 0.120 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 20 | 0.120 |
Why?
| | Nitrites | 3 | 2016 | 75 | 0.120 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 358 | 0.110 |
Why?
| | Adrenal Cortex Hormones | 3 | 2006 | 497 | 0.110 |
Why?
| | Tail | 4 | 1998 | 29 | 0.110 |
Why?
| | Primary Cell Culture | 1 | 2014 | 149 | 0.110 |
Why?
| | Convulsants | 1 | 1993 | 6 | 0.110 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 2005 | 29 | 0.110 |
Why?
| | Carbolines | 1 | 1993 | 27 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 811 | 0.110 |
Why?
| | Acute-Phase Reaction | 2 | 2007 | 39 | 0.110 |
Why?
| | Hyperalgesia | 3 | 2016 | 107 | 0.110 |
Why?
| | Colitis | 1 | 2016 | 223 | 0.110 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 43 | 0.110 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2013 | 61 | 0.110 |
Why?
| | Bradykinin | 1 | 2013 | 42 | 0.110 |
Why?
| | Molecular Probes | 1 | 2013 | 30 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2012 | 1019 | 0.110 |
Why?
| | Amnesia | 2 | 2011 | 42 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1075 | 0.110 |
Why?
| | Pulmonary Fibrosis | 1 | 2016 | 323 | 0.110 |
Why?
| | Mental Disorders | 1 | 2020 | 892 | 0.110 |
Why?
| | Reaction Time | 3 | 2012 | 376 | 0.110 |
Why?
| | Telemetry | 1 | 2013 | 36 | 0.110 |
Why?
| | Cues | 3 | 2015 | 300 | 0.100 |
Why?
| | Diaphragm | 3 | 1998 | 33 | 0.100 |
Why?
| | Female | 20 | 2019 | 59499 | 0.100 |
Why?
| | Fetal Blood | 1 | 2014 | 270 | 0.100 |
Why?
| | Aged | 5 | 2008 | 19073 | 0.100 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2012 | 12 | 0.100 |
Why?
| | Macrophages | 2 | 2000 | 1262 | 0.100 |
Why?
| | Synaptotagmin I | 1 | 2012 | 13 | 0.100 |
Why?
| | Life Style | 2 | 2005 | 430 | 0.100 |
Why?
| | Thymus Gland | 3 | 2008 | 296 | 0.100 |
Why?
| | Phenylephrine | 2 | 2001 | 71 | 0.100 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 78 | 0.100 |
Why?
| | Area Under Curve | 1 | 2013 | 274 | 0.100 |
Why?
| | Body Fat Distribution | 1 | 2012 | 46 | 0.100 |
Why?
| | Injections, Subcutaneous | 2 | 2003 | 134 | 0.100 |
Why?
| | Lipid Bilayers | 1 | 2013 | 99 | 0.100 |
Why?
| | Rats, Nude | 1 | 2012 | 26 | 0.100 |
Why?
| | Cell Communication | 1 | 2014 | 280 | 0.100 |
Why?
| | Gliosarcoma | 1 | 1992 | 8 | 0.100 |
Why?
| | Thiazepines | 2 | 2013 | 5 | 0.100 |
Why?
| | Caspase 1 | 1 | 2012 | 140 | 0.100 |
Why?
| | Lymphocyte Transfusion | 1 | 1992 | 19 | 0.100 |
Why?
| | Cattle | 1 | 2014 | 920 | 0.100 |
Why?
| | Lymphocyte Count | 2 | 2003 | 133 | 0.100 |
Why?
| | Lymphocytes | 3 | 2011 | 330 | 0.100 |
Why?
| | Saimiri | 1 | 2011 | 6 | 0.100 |
Why?
| | Uric Acid | 1 | 2012 | 148 | 0.100 |
Why?
| | Neurobiology | 1 | 2011 | 16 | 0.100 |
Why?
| | Locus Coeruleus | 1 | 2011 | 19 | 0.090 |
Why?
| | Body Composition | 1 | 2015 | 590 | 0.090 |
Why?
| | Cell Survival | 1 | 2014 | 1021 | 0.090 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 37 | 0.090 |
Why?
| | Biosensing Techniques | 1 | 2012 | 100 | 0.090 |
Why?
| | Cells, Cultured | 3 | 2014 | 3886 | 0.090 |
Why?
| | Laparotomy | 1 | 2011 | 103 | 0.090 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 8 | 0.090 |
Why?
| | Endocrine Glands | 1 | 1990 | 15 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 253 | 0.090 |
Why?
| | Interleukin-2 | 1 | 1992 | 413 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 313 | 0.090 |
Why?
| | Mice | 7 | 2021 | 14869 | 0.090 |
Why?
| | DNA Primers | 1 | 2011 | 510 | 0.090 |
Why?
| | Microinjections | 2 | 2008 | 76 | 0.090 |
Why?
| | Rats, Inbred Strains | 6 | 1995 | 362 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 386 | 0.090 |
Why?
| | Epinephrine | 3 | 2004 | 163 | 0.090 |
Why?
| | Pain | 4 | 2011 | 705 | 0.090 |
Why?
| | Immunotherapy, Adoptive | 1 | 1992 | 184 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 287 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1629 | 0.080 |
Why?
| | Cell Count | 2 | 2002 | 303 | 0.080 |
Why?
| | Insulin | 2 | 2016 | 2079 | 0.080 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 23 | 0.080 |
Why?
| | Glucose | 1 | 2014 | 897 | 0.080 |
Why?
| | CA1 Region, Hippocampal | 1 | 2009 | 29 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 429 | 0.080 |
Why?
| | Neutrophils | 3 | 2011 | 1176 | 0.080 |
Why?
| | Naltrexone | 4 | 1994 | 83 | 0.080 |
Why?
| | Analgesics | 1 | 1990 | 158 | 0.080 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2001 | 61 | 0.080 |
Why?
| | Lipids | 1 | 2012 | 580 | 0.080 |
Why?
| | Reference Values | 5 | 2007 | 743 | 0.080 |
Why?
| | Weight Loss | 1 | 1993 | 642 | 0.080 |
Why?
| | Nadolol | 1 | 2008 | 5 | 0.080 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 48 | 0.080 |
Why?
| | Flow Cytometry | 2 | 2003 | 1083 | 0.080 |
Why?
| | Pyrazines | 1 | 2008 | 71 | 0.080 |
Why?
| | Immunity | 2 | 2000 | 121 | 0.070 |
Why?
| | Nerve Net | 1 | 2010 | 226 | 0.070 |
Why?
| | Isoproterenol | 1 | 2008 | 106 | 0.070 |
Why?
| | Substantia Nigra | 1 | 2008 | 38 | 0.070 |
Why?
| | Injections, Intraventricular | 4 | 1998 | 71 | 0.070 |
Why?
| | Blood Glucose | 1 | 2016 | 1828 | 0.070 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 29 | 0.070 |
Why?
| | Computational Biology | 1 | 2011 | 530 | 0.070 |
Why?
| | Adrenergic beta-Agonists | 1 | 2008 | 126 | 0.070 |
Why?
| | Aggression | 1 | 1989 | 183 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 547 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2285 | 0.070 |
Why?
| | Mesentery | 2 | 1998 | 53 | 0.070 |
Why?
| | Recombinant Proteins | 5 | 2000 | 1230 | 0.070 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 13 | 0.070 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2006 | 38 | 0.070 |
Why?
| | Fluoxetine | 1 | 2006 | 46 | 0.070 |
Why?
| | Piperazines | 1 | 2008 | 309 | 0.070 |
Why?
| | Estrous Cycle | 1 | 2006 | 14 | 0.070 |
Why?
| | Immunity, Cellular | 2 | 2005 | 248 | 0.070 |
Why?
| | Cell Adhesion Molecules | 1 | 2007 | 168 | 0.070 |
Why?
| | Labetalol | 1 | 2005 | 5 | 0.060 |
Why?
| | Peritoneum | 2 | 2003 | 36 | 0.060 |
Why?
| | Pulmonary Edema | 1 | 2006 | 115 | 0.060 |
Why?
| | Mianserin | 1 | 2005 | 3 | 0.060 |
Why?
| | Methyltyrosines | 1 | 2005 | 3 | 0.060 |
Why?
| | Hypophysectomy | 1 | 2005 | 15 | 0.060 |
Why?
| | Hypertrophy | 2 | 2007 | 109 | 0.060 |
Why?
| | Immunoglobulin alpha-Chains | 1 | 2005 | 2 | 0.060 |
Why?
| | Postural Balance | 1 | 2008 | 183 | 0.060 |
Why?
| | RNA | 1 | 2011 | 809 | 0.060 |
Why?
| | Liver | 3 | 2006 | 1637 | 0.060 |
Why?
| | Evoked Potentials | 3 | 1996 | 108 | 0.060 |
Why?
| | Phosphorylation | 3 | 2017 | 1569 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1729 | 0.060 |
Why?
| | Exocytosis | 1 | 2005 | 89 | 0.060 |
Why?
| | Spectrophotometry | 1 | 2005 | 48 | 0.060 |
Why?
| | Hypertension | 1 | 2013 | 1056 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2002 | 59 | 0.060 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.060 |
Why?
| | Progesterone | 1 | 2006 | 232 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 72 | 0.060 |
Why?
| | Blood Pressure | 4 | 2015 | 1538 | 0.060 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 32 | 0.060 |
Why?
| | Down-Regulation | 1 | 2006 | 594 | 0.060 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2004 | 56 | 0.060 |
Why?
| | Lymphocyte Activation | 2 | 2000 | 1037 | 0.060 |
Why?
| | Antibody Specificity | 1 | 2004 | 176 | 0.060 |
Why?
| | Cholesterol, HDL | 1 | 2005 | 183 | 0.060 |
Why?
| | Concanavalin A | 1 | 2003 | 74 | 0.060 |
Why?
| | Brain Neoplasms | 1 | 1992 | 979 | 0.060 |
Why?
| | Biomarkers | 3 | 2015 | 3408 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4694 | 0.060 |
Why?
| | Immunologic Factors | 1 | 2005 | 220 | 0.060 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 209 | 0.060 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2003 | 16 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2004 | 141 | 0.050 |
Why?
| | History, 21st Century | 1 | 2004 | 159 | 0.050 |
Why?
| | Estrogens | 1 | 2006 | 312 | 0.050 |
Why?
| | Hot Temperature | 2 | 2021 | 302 | 0.050 |
Why?
| | Leukocytes | 1 | 2005 | 276 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2005 | 355 | 0.050 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 6 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2006 | 373 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 32 | 0.050 |
Why?
| | History, 20th Century | 1 | 2004 | 264 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2005 | 307 | 0.050 |
Why?
| | Analgesia | 2 | 1994 | 82 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 8632 | 0.050 |
Why?
| | Nucleus Accumbens | 2 | 2016 | 124 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 315 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 467 | 0.050 |
Why?
| | Naloxone | 3 | 2012 | 97 | 0.050 |
Why?
| | Forecasting | 1 | 2004 | 330 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 286 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2004 | 313 | 0.050 |
Why?
| | Cell Membrane | 1 | 2005 | 680 | 0.050 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 6 | 0.050 |
Why?
| | Adult | 9 | 2019 | 30546 | 0.050 |
Why?
| | Cell Division | 1 | 2003 | 758 | 0.050 |
Why?
| | Reflex, Startle | 2 | 2015 | 57 | 0.050 |
Why?
| | Epitopes | 1 | 2003 | 435 | 0.050 |
Why?
| | Learning | 3 | 2008 | 350 | 0.050 |
Why?
| | Injections, Intravenous | 2 | 1998 | 198 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2001 | 32 | 0.050 |
Why?
| | Mycobacteriaceae | 1 | 2021 | 21 | 0.050 |
Why?
| | Neurons, Afferent | 2 | 1998 | 85 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2001 | 33 | 0.050 |
Why?
| | Spironolactone | 1 | 2001 | 28 | 0.050 |
Why?
| | Macrophage-1 Antigen | 1 | 2000 | 33 | 0.050 |
Why?
| | Skin | 2 | 2002 | 655 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 92 | 0.050 |
Why?
| | Obesity | 1 | 1993 | 2508 | 0.050 |
Why?
| | Health Status | 1 | 2006 | 722 | 0.050 |
Why?
| | Complement Activation | 1 | 2003 | 340 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 2796 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 287 | 0.040 |
Why?
| | United States | 1 | 2016 | 12182 | 0.040 |
Why?
| | Hypogravity | 1 | 1999 | 5 | 0.040 |
Why?
| | Receptors, Mineralocorticoid | 1 | 1999 | 7 | 0.040 |
Why?
| | Erythrocytes | 1 | 2005 | 591 | 0.040 |
Why?
| | Chronic Disease | 1 | 2006 | 1578 | 0.040 |
Why?
| | Radiation Injuries, Experimental | 1 | 1999 | 25 | 0.040 |
Why?
| | Cells | 1 | 1999 | 22 | 0.040 |
Why?
| | Radiometry | 1 | 1999 | 42 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2016 | 12549 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1999 | 127 | 0.040 |
Why?
| | Electrophysiology | 2 | 1999 | 201 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 591 | 0.040 |
Why?
| | Social Isolation | 1 | 1999 | 52 | 0.040 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1999 | 67 | 0.040 |
Why?
| | C-Reactive Protein | 2 | 2015 | 362 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 362 | 0.040 |
Why?
| | Restraint, Physical | 3 | 2010 | 67 | 0.040 |
Why?
| | Middle Aged | 3 | 2016 | 26735 | 0.040 |
Why?
| | alpha-MSH | 1 | 1998 | 5 | 0.040 |
Why?
| | Eating | 3 | 2000 | 344 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 211 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 1999 | 73 | 0.040 |
Why?
| | Polysomnography | 1 | 2019 | 135 | 0.040 |
Why?
| | Staphylococcal Infections | 2 | 2000 | 340 | 0.040 |
Why?
| | Administration, Oral | 1 | 2001 | 728 | 0.040 |
Why?
| | Peritoneal Cavity | 1 | 1998 | 23 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 318 | 0.040 |
Why?
| | Escherichia coli | 1 | 2002 | 720 | 0.040 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 3 | 2007 | 254 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 1982 | 0.040 |
Why?
| | Bacteriophages | 1 | 1999 | 75 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 128 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 159 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1620 | 0.040 |
Why?
| | Antigens, CD | 1 | 2000 | 442 | 0.040 |
Why?
| | Individuality | 1 | 2019 | 146 | 0.040 |
Why?
| | Anesthesia | 2 | 1990 | 117 | 0.040 |
Why?
| | Models, Molecular | 2 | 2013 | 1369 | 0.040 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 257 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2785 | 0.040 |
Why?
| | Altitude | 1 | 2001 | 432 | 0.040 |
Why?
| | Oxytocics | 1 | 1997 | 15 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1999 | 308 | 0.040 |
Why?
| | Weight Gain | 1 | 2000 | 453 | 0.040 |
Why?
| | Monitoring, Physiologic | 2 | 2008 | 249 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3252 | 0.040 |
Why?
| | Occupational Exposure | 1 | 1999 | 255 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2016 | 4 | 0.030 |
Why?
| | Receptors, Purinergic P2X5 | 1 | 2016 | 4 | 0.030 |
Why?
| | Dinoprostone | 1 | 1997 | 184 | 0.030 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2016 | 13 | 0.030 |
Why?
| | p21-Activated Kinases | 1 | 2016 | 14 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 41 | 0.030 |
Why?
| | Sciatic Neuropathy | 1 | 2016 | 24 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1147 | 0.030 |
Why?
| | Orientation | 1 | 1996 | 39 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 1998 | 227 | 0.030 |
Why?
| | Attention | 1 | 2019 | 393 | 0.030 |
Why?
| | Neuroglia | 1 | 2017 | 150 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 1996 | 53 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 228 | 0.030 |
Why?
| | Azides | 1 | 1996 | 46 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 208 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 198 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2016 | 126 | 0.030 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 43 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 260 | 0.030 |
Why?
| | Stem Cells | 1 | 1999 | 546 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 127 | 0.030 |
Why?
| | Spinal Cord | 2 | 2004 | 347 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 144 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 380 | 0.030 |
Why?
| | Immobilization | 1 | 2015 | 42 | 0.030 |
Why?
| | Drug Synergism | 2 | 2011 | 316 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 206 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1144 | 0.030 |
Why?
| | Nylons | 1 | 1995 | 18 | 0.030 |
Why?
| | Cytological Techniques | 1 | 1995 | 23 | 0.030 |
Why?
| | Neck | 1 | 1995 | 83 | 0.030 |
Why?
| | Macrophage Activation | 1 | 1996 | 164 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 4622 | 0.030 |
Why?
| | Melatonin | 1 | 2015 | 105 | 0.030 |
Why?
| | Cholesterol | 1 | 1996 | 367 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 493 | 0.030 |
Why?
| | Neurogenesis | 1 | 2014 | 102 | 0.030 |
Why?
| | Memory, Short-Term | 2 | 2008 | 225 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 339 | 0.030 |
Why?
| | Fasting | 1 | 2014 | 240 | 0.030 |
Why?
| | Neural Inhibition | 1 | 1994 | 140 | 0.030 |
Why?
| | Clonidine | 1 | 2013 | 22 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1992 | 19 | 0.030 |
Why?
| | Static Electricity | 1 | 2013 | 114 | 0.030 |
Why?
| | Amitriptyline | 1 | 2013 | 21 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2013 | 87 | 0.030 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 5 | 0.030 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 9 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 157 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2012 | 40 | 0.030 |
Why?
| | Anthropometry | 1 | 1993 | 182 | 0.030 |
Why?
| | Sex Factors | 2 | 2008 | 1715 | 0.030 |
Why?
| | Adolescent Health Services | 1 | 1993 | 68 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2012 | 135 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 76 | 0.030 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2012 | 2 | 0.030 |
Why?
| | Hand Strength | 2 | 2004 | 96 | 0.030 |
Why?
| | Pain Threshold | 1 | 2012 | 67 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2013 | 157 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 9088 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2012 | 65 | 0.020 |
Why?
| | Self Administration | 1 | 2012 | 122 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 90 | 0.020 |
Why?
| | Adolescent | 3 | 2004 | 17841 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 164 | 0.020 |
Why?
| | Linear Models | 2 | 2004 | 768 | 0.020 |
Why?
| | Sialoglycoproteins | 2 | 2004 | 159 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 1992 | 228 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 146 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1992 | 154 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2008 | 6347 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2012 | 136 | 0.020 |
Why?
| | Behavior Therapy | 1 | 1993 | 226 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 301 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 1990 | 46 | 0.020 |
Why?
| | Risk Assessment | 1 | 1999 | 2968 | 0.020 |
Why?
| | Pentobarbital | 1 | 1990 | 16 | 0.020 |
Why?
| | Urethane | 1 | 1990 | 41 | 0.020 |
Why?
| | Vasopressins | 1 | 1990 | 56 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1992 | 849 | 0.020 |
Why?
| | Immunity, Mucosal | 1 | 2011 | 84 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 9 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2010 | 162 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 27 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 30 | 0.020 |
Why?
| | Drinking | 2 | 1999 | 33 | 0.020 |
Why?
| | Noise | 1 | 2010 | 68 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 156 | 0.020 |
Why?
| | Bites and Stings | 1 | 1989 | 30 | 0.020 |
Why?
| | Program Evaluation | 1 | 1993 | 822 | 0.020 |
Why?
| | Nanoparticles | 1 | 2012 | 313 | 0.020 |
Why?
| | Posture | 1 | 1989 | 151 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 434 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 116 | 0.020 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2007 | 4 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 778 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 1949 | 0.020 |
Why?
| | E-Selectin | 1 | 2007 | 53 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 152 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 1890 | 0.020 |
Why?
| | Action Potentials | 3 | 1999 | 406 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 154 | 0.020 |
Why?
| | Epithelial Sodium Channels | 1 | 2006 | 12 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2006 | 71 | 0.020 |
Why?
| | Cell Line | 1 | 1992 | 2637 | 0.020 |
Why?
| | Sodium Channels | 1 | 2006 | 62 | 0.020 |
Why?
| | Models, Animal | 1 | 2007 | 344 | 0.020 |
Why?
| | Epithelium | 1 | 2006 | 295 | 0.020 |
Why?
| | Autoimmunity | 1 | 1991 | 813 | 0.020 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 18 | 0.010 |
Why?
| | Receptors, HIV | 1 | 2004 | 23 | 0.010 |
Why?
| | Bronchi | 1 | 2006 | 232 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 21 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 33 | 0.010 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2004 | 25 | 0.010 |
Why?
| | Injections, Spinal | 1 | 2004 | 101 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 79 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1016 | 0.010 |
Why?
| | Drug Implants | 2 | 1996 | 70 | 0.010 |
Why?
| | Complement C4a | 1 | 2003 | 6 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 132 | 0.010 |
Why?
| | Social Environment | 2 | 1996 | 283 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 159 | 0.010 |
Why?
| | Histamine | 1 | 2003 | 56 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2004 | 144 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2003 | 173 | 0.010 |
Why?
| | Isometric Contraction | 1 | 2004 | 155 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 257 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 326 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2004 | 785 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 29 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2001 | 22 | 0.010 |
Why?
| | Mental Status Schedule | 1 | 2001 | 33 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 288 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2004 | 389 | 0.010 |
Why?
| | Mathematics | 1 | 2001 | 101 | 0.010 |
Why?
| | Cholecystokinin | 1 | 2000 | 15 | 0.010 |
Why?
| | Menstrual Cycle | 1 | 2001 | 108 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2006 | 731 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2000 | 73 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 2000 | 174 | 0.010 |
Why?
| | Dimerization | 1 | 2000 | 176 | 0.010 |
Why?
| | Listeriosis | 1 | 2000 | 61 | 0.010 |
Why?
| | Ovary | 1 | 2001 | 191 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 140 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 413 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 2000 | 67 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 10466 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 4411 | 0.010 |
Why?
| | Cerebellum | 1 | 2000 | 200 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 588 | 0.010 |
Why?
| | Glossopharyngeal Nerve | 1 | 1998 | 11 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 1998 | 98 | 0.010 |
Why?
| | Afferent Pathways | 1 | 1998 | 42 | 0.010 |
Why?
| | Nodose Ganglion | 1 | 1997 | 5 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 2000 | 380 | 0.010 |
Why?
| | Neoplasms | 1 | 2011 | 2097 | 0.010 |
Why?
| | Amnesia, Retrograde | 1 | 1996 | 3 | 0.010 |
Why?
| | Appetitive Behavior | 1 | 1996 | 8 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3003 | 0.010 |
Why?
| | Sodium Azide | 1 | 1996 | 6 | 0.010 |
Why?
| | Synaptic Membranes | 1 | 1996 | 18 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1996 | 36 | 0.010 |
Why?
| | Zymosan | 1 | 1996 | 64 | 0.010 |
Why?
| | Space Perception | 1 | 1996 | 64 | 0.010 |
Why?
| | Acute Disease | 1 | 1998 | 911 | 0.010 |
Why?
| | Chlorisondamine | 1 | 1994 | 4 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 7 | 0.010 |
Why?
| | Child | 1 | 1993 | 18412 | 0.010 |
Why?
| | Skin Temperature | 1 | 1993 | 16 | 0.010 |
Why?
| | Binding Sites | 1 | 1996 | 1168 | 0.010 |
Why?
| | Pyramidal Tracts | 1 | 1992 | 20 | 0.010 |
Why?
| | Cold Temperature | 1 | 1993 | 126 | 0.010 |
Why?
| | Mitochondria | 1 | 1996 | 747 | 0.010 |
Why?
| | Regression Analysis | 1 | 1992 | 944 | 0.010 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1988 | 3 | 0.000 |
Why?
|
|
Fleshner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|